Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Mar 1;88(5):1756–1759. doi: 10.1073/pnas.88.5.1756

Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.

R D Levere 1, Y F Gong 1, A Kappas 1, D J Bucher 1, G P Wormser 1, N G Abraham 1
PMCID: PMC51103  PMID: 2000384

Abstract

The effects of heme alone and heme administered together with 3'-azido-3'-deoxythymidine (AZT) on human immunodeficiency virus replication in human peripheral blood lymphocytes and in the H9 cell line were studied. Heme enhanced the antiviral action of AZT against both drug-resistant and drug-sensitive viral strains; the heme effect was more pronounced against the latter. Moreover, heme alone displayed a significant ability to inhibit viral replication in concentrations markedly smaller than those required to inhibit the reverse transcriptase of Rauscher murine leukemia virus. The results of this study extend the range of pharmacological actions that metalloporphyrins exert in biological systems and suggest that further study of the interactions of the natural compound heme and human immunodeficiency virus chemotherapeutic agents such as AZT may be useful.

Full text

PDF
1756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham N. G., Bucher D., Niranjan U., Brown A. C., Lutton J. D., Distenfeld A., Ahmed T., Levere R. D. Microenvironmental toxicity of azidothymidine: partial sparing with hemin. Blood. 1989 Jul;74(1):139–144. [PubMed] [Google Scholar]
  2. Beru N., Goldwasser E. The regulation of heme biosynthesis during erythropoietin-induced erythroid differentiation. J Biol Chem. 1985 Aug 5;260(16):9251–9257. [PubMed] [Google Scholar]
  3. Brown A., Lutton J. D., Nelson J., Abraham N. G., Levere R. D. Microenvironmental cytokines and expression of erythroid heme metabolic enzymes. Blood Cells. 1987;13(1-2):123–136. [PubMed] [Google Scholar]
  4. Chen J. J., London I. M. Hemin enhances the differentiation of mouse 3T3 cells to adipocytes. Cell. 1981 Oct;26(1 Pt 1):117–122. doi: 10.1016/0092-8674(81)90039-8. [DOI] [PubMed] [Google Scholar]
  5. Chernick R. J., Martasek P., Levere R. D., Margreiter R., Abraham N. G. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology. 1989 Sep;10(3):365–369. doi: 10.1002/hep.1840100320. [DOI] [PubMed] [Google Scholar]
  6. Dainiak N., Worthington M., Riordan M. A., Kreczko S., Goldman L. 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol. 1988 Jul;69(3):299–304. doi: 10.1111/j.1365-2141.1988.tb02366.x. [DOI] [PubMed] [Google Scholar]
  7. Drummond G. S., Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466–6470. doi: 10.1073/pnas.78.10.6466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  9. Furman P. A., Fyfe J. A., St Clair M. H., Weinhold K., Rideout J. L., Freeman G. A., Lehrman S. N., Bolognesi D. P., Broder S., Mitsuya H. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8333–8337. doi: 10.1073/pnas.83.21.8333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Galbraith R. A., Kappas A. Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria. Hepatology. 1989 Jun;9(6):882–888. doi: 10.1002/hep.1840090616. [DOI] [PubMed] [Google Scholar]
  11. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  12. Granick J. L., Sassa S. Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture. J Biol Chem. 1978 Aug 10;253(15):5402–5406. [PubMed] [Google Scholar]
  13. Groopman J. E. Status of colony-stimulating factors in cancer and AIDS. Semin Oncol. 1990 Feb;17(1 Suppl 1):31–41. [PubMed] [Google Scholar]
  14. Haile D. J., Rouault T. A., Harford J. B., Klausner R. D. The inhibition of the iron responsive element RNA-protein interaction by heme does not mimic in vivo iron regulation. J Biol Chem. 1990 Aug 5;265(22):12786–12789. [PubMed] [Google Scholar]
  15. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  16. Hogan D., Card R. T., Ghadially R., McSheffrey J. B., Lane P. Human immunodeficiency virus infection and porphyria cutanea tarda. J Am Acad Dermatol. 1989 Jan;20(1):17–20. doi: 10.1016/s0190-9622(89)70002-5. [DOI] [PubMed] [Google Scholar]
  17. Ishii D. N., Maniatis G. M. Haemin promotes rapid neurite outgrowth in cultured mouse neuroblastoma cells. Nature. 1978 Jul 27;274(5669):372–374. doi: 10.1038/274372a0. [DOI] [PubMed] [Google Scholar]
  18. Kappas A., Drummond G. S. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest. 1986 Feb;77(2):335–339. doi: 10.1172/JCI112309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kappas A., Drummond G. S., Manola T., Petmezaki S., Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics. 1988 Apr;81(4):485–497. [PubMed] [Google Scholar]
  20. Larder B. A., Kemp S. D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science. 1989 Dec 1;246(4934):1155–1158. doi: 10.1126/science.2479983. [DOI] [PubMed] [Google Scholar]
  21. Levere R. D., Granick S. Control of hemoglobin synthesis in the cultured chick blastoderm by delta-aminolevulinic acid synthetase: increase in the rate of hemoglobin formation with delta-aminolevulinic acid. Proc Natl Acad Sci U S A. 1965 Jul;54(1):134–137. doi: 10.1073/pnas.54.1.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Levere R. D., Martasek P., Escalante B., Schwartzman M. L., Abraham N. G. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 1990 Jul;86(1):213–219. doi: 10.1172/JCI114686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lin J. J., Daniels-McQueen S., Patino M. M., Gaffield L., Walden W. E., Thach R. E. Derepression of ferritin messenger RNA translation by hemin in vitro. Science. 1990 Jan 5;247(4938):74–77. doi: 10.1126/science.2294594. [DOI] [PubMed] [Google Scholar]
  24. Lutton J. D., Ibraham N. G., Friedland M., Levere R. D. The toxic effects of heavy metals on rat bone marrow in vitro erythropoiesis: protective role of hemin and zinc. Environ Res. 1984 Oct;35(1):97–103. doi: 10.1016/0013-9351(84)90116-6. [DOI] [PubMed] [Google Scholar]
  25. Mann D. L., O'Brien S. J., Gilbert D. A., Reid Y., Popovic M., Read-Connole E., Gallo R. C., Gazdar A. F. Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res Hum Retroviruses. 1989 Jun;5(3):253–255. doi: 10.1089/aid.1989.5.253. [DOI] [PubMed] [Google Scholar]
  26. Popovic M., Read-Connole E., Gallo R. C. T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet. 1984 Dec 22;2(8417-8418):1472–1473. doi: 10.1016/s0140-6736(84)91666-0. [DOI] [PubMed] [Google Scholar]
  27. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  28. Reynaud P., Goodfellow K., Svec F. Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis. 1990 May;161(5):1032–1033. doi: 10.1093/infdis/161.5.1032. [DOI] [PubMed] [Google Scholar]
  29. Richman D. D., Fischl M. A., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Hirsch M. S. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):192–197. doi: 10.1056/NEJM198707233170402. [DOI] [PubMed] [Google Scholar]
  30. Schmitt F. A., Bigley J. W., McKinnis R., Logue P. E., Evans R. W., Drucker J. L. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1988 Dec 15;319(24):1573–1578. doi: 10.1056/NEJM198812153192404. [DOI] [PubMed] [Google Scholar]
  31. Spivak J. L., Barnes D. C., Fuchs E., Quinn T. C. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989 Jun 2;261(21):3104–3107. [PubMed] [Google Scholar]
  32. St Clair M. H., Richards C. A., Spector T., Weinhold K. J., Miller W. H., Langlois A. J., Furman P. A. 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother. 1987 Dec;31(12):1972–1977. doi: 10.1128/aac.31.12.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tsutsui K., Mueller G. C. Hemin inhibits virion-associated reverse transcriptase of murine leukemia virus. Biochem Biophys Res Commun. 1987 Dec 16;149(2):628–634. doi: 10.1016/0006-291x(87)90414-1. [DOI] [PubMed] [Google Scholar]
  34. Walker R. E., Parker R. I., Kovacs J. A., Masur H., Lane H. C., Carleton S., Kirk L. E., Gralnick H. R., Fauci A. S. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med. 1988 Mar;108(3):372–376. doi: 10.7326/0003-4819-108-3-372. [DOI] [PubMed] [Google Scholar]
  35. Wissel P. S., Sordillo P., Anderson K. E., Sassa S., Savillo R. L., Kappas A. Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol. 1987 May;25(1):107–113. doi: 10.1002/ajh.2830250112. [DOI] [PubMed] [Google Scholar]
  36. Yarchoan R., Klecker R. W., Weinhold K. J., Markham P. D., Lyerly H. K., Durack D. T., Gelmann E., Lehrman S. N., Blum R. M., Barry D. W. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. doi: 10.1016/s0140-6736(86)92808-4. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES